News Nature: "Sidewinder" tech a leap forward in DNA synthesis A new technology developed at Caltech represents a breakthrough in DNA synthesis, essentially allowing de novo sequence creation.
News ASCO: BMS hails "compelling" phase 3 celmod readout Bristol Myers Squibb has high hopes for its celmod drugs, and a phase 3 trial for mezigdomide in multiple myeloma at ASCO26 has delivered the goods.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
